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Abstract
Background: The pathophysiology of obesity and type 2 diabetes mellitus is associated with abnormalities in endocrine
signaling in adipose tissue and one of the key signaling affectors operative in these disorders is the nuclear hormone
transcription factor peroxisome proliferator-activated receptor-c (PPARc). PPARc has pleiotropic functions affecting a wide
range of fundamental biological processes including the regulation of genes that modulate insulin sensitivity, adipocyte
differentiation, inflammation and atherosclerosis. To date, only a limited number of direct targets for PPARc have been
identified through research using the well established pre-adipogenic cell line, 3T3-L1. In order to obtain a genome-wide
view of PPARc binding sites, we applied the pair end-tagging technology (ChIP-PET) to map PPARc binding sites in 3T3-L1
preadipocyte cells.
Methodology/Principal Findings: Coupling gene expression profile analysis with ChIP-PET, we identified in a genome-wide
manner over 7700 DNA binding sites of the transcription factor PPARc and its heterodimeric partner RXR during the course
of adipocyte differentiation. Our validation studies prove that the identified sites are bona fide binding sites for both PPARc
and RXR and that they are functionally capable of driving PPARc specific transcription. Our results strongly indicate that
PPARc is the predominant heterodimerization partner for RXR during late stages of adipocyte differentiation. Additionally,
we find that PPARc/RXR association is enriched within the proximity of the 59 region of the transcription start site and this
association is significantly associated with transcriptional up-regulation of genes involved in fatty acid and lipid metabolism
confirming the role of PPARc as the master transcriptional regulator of adipogenesis. Evolutionary conservation analysis of
these binding sites is greater when adjacent to up-regulated genes than down-regulated genes, suggesting the primordial
function of PPARc/RXR is in the induction of genes. Our functional validations resulted in identifying novel PPARc direct
targets that have not been previously reported to promote adipogenic differentiation.
Conclusions/Significance: We have identified in a genome-wide manner the binding sites of PPARc and RXR during the
course of adipogenic differentiation in 3T3L1 cells, and provide an important resource for the study of PPARc function in the
context of adipocyte differentiation.
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Introduction
The pathophysiology of obesity and type 2 diabetes mellitus is
associated with abnormalities in endocrine signaling in adipose
tissue and one of the key signaling affectors operative in these
disorders is the nuclear hormone transcription factor peroxisome
proliferator-activated receptor-c (PPARc) [1–4]. PPARc has
pleiotropic functions affecting a wide range of fundamental
biological processes including the regulation of genes that
modulate insulin sensitivity, adipocyte differentiation, inflamma-
tion and atherosclerosis. Recent evidence has also implicated
PPARc in cell cycle control and cancer progression [5–9]. PPARc
is activated by several naturally occurring compounds, and
synthetic molecules, such as thiazolidinediones, which are actively
used in the therapy of type 2 diabetes [8,10–12]. To date, only a
limited number of direct targets for PPARc have been identified
through research using the well established pre-adipogenic cell
line, 3T3-L1.
Recently, in silico analysis of the human genome sequence has
been carried out to identify direct target genes of PPARc [13]. In
addition, a model for PPARc binding preferences using position
weight matrices derived from all published Peroxisome Prolif-
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activation, PPARc heterodimerizes with the retinoid X receptor
(RXR) and transcriptionally regulates target genes by binding to
response elements (PPRE) consisting of a hexameric DNA core
recognition motif spaced by one nucleotide (DR-1, PPREs; 59-
AGGTCANAGGTCA-39), where PPARc occupies the 59-half of
the motif [15,16]. However, in silico predictions poorly correlate
with in vivo transcription factor binding, and as such, this approach
has limited ability to predict bona fide PPARc binding.
To better define the transcriptional control functions of PPARc
and its heterodimerization partner, RXR, during adipogenesis, we
employed the paired-end ditag (PET) technology to characterize
chromatin immunoprecipitated (ChIP)-enriched DNA fragments
and mapped, in an unbiased manner, the binding sites of these
nuclear hormone receptors (NHR) on a genome-wide scale.
Previous work from our group has shown the utility of this
approach in assessing transcription factor control mechanisms,
and the potential advantages of sequenced based methodologies
over hybridization approaches in mapping transcription factor
binding sites [17]. Combining the ChIP-PET identification of
PPARc and of RXR binding sites with PPARc dependent gene
expression analysis of cells undergoing adipogenesis, we have
comprehensively assessed their binding site usage and the
regulatory mechanisms governing the transcriptional control of
direct target genes. Our genomic scale data suggests that RXR is
the major heterodimeric partner for PPARc during adipocyte
differentiation and maturation. Additionally, we find that PPARc/
RXR association is enriched within the proximity of the 59 region
of the transcription start site and is significantly associated with
transcriptional up-regulation of genes confirming the role of
PPARc as the master transcriptional regulator of adipogenesis.
Interestingly, we observed that during the early stages of adipocyte
differentiation (fibroblasts to preadipocytes), the proportion of
repressed genes were higher to those of genes that were induced.
This relation was reversed after day 3, suggesting a concomitant
with the switch from early to terminal adipocyte differentiation
and marked by the induction of adipogenic maintenance genes.
Our validation studies prove that the identified sites are bona
fide binding sites and that they are transcriptionally capable of
driving PPARc specific transcription. In addition, we have
functionally assessed PPARc/RXR target genes and deduced
the metabolic pathways that they activate during the course of
differentiation.
Results
Utilizing 3T3-L1 cells to investigate PPARc dependent
regulatory networks during adipogenesis
We used the well established 3T3-L1 cell line as a model system
for adipocyte differentiation. Following a protocol schematically
outlined in Figure 1C, 3T3-L1 cells were differentiated into
adipocytes 4 days post treatment with dexamethasone and IBMX,
Figure 1. 3T3L1 cells as model system for adipocyte differentiation. Undifferentiated 3T3-L1 fibroblast undergoes adipogenesis upon
treatment with Dexamethasone and IBMX, followed by Insulin and Rosiglitazone after two days. Adipogenesis was completely abrogated by PPARc
specific siRNA. a) Adipogenesis was monitored by Western blot for induction of adipocyte-specific marker genes. Beta-actin served as loading control.
b) accumulation of lipid droplets in differentiated 3T3-L1 cells was visualized by OilRed-O staining c) Schematic outline of the experimental setup:
3T3-L1 cell were treated with Dexamethasone and IBMX at confluency 2 days before stimulation with Rosiglitazone and Insulin. Samples for ChIP
were taken at day 4. Samples for expression analysis were taken at all time points indicated. For each time point cells treated with PPARc specific and
control siRNA prior to the differentiation protocol were collected in 3 biological replicates. Microarray data was submitted to the GEO repository
under GEO Submission (GSE12929).
doi:10.1371/journal.pone.0004907.g001
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tion was verified both by western blot for adipocyte specific
markers and accumulation of lipids within the cells as detected by
Oil-Red O staining. 3T3-L1 cell transfected with PPARc specific
siRNA prior to differentiation completely abolished this process
(Figures 1 A, B).
Genes differentially expressed by PPARc siRNA during
adipogenesis provide the first stratum in constructing a
PPARc dependent regulatory network
We followed gene expression changes during adipogenesis of
3T3-L1 cells treated with PPARc-specific siRNA (PPARc knock
down (KD)) and those treated with control non-targeting siRNA
using Illumina Sentrix BeadhipsRef-8. RNA was extracted at each
timepoint (everyday). Analysis using all time-points (days 22t o6 )
revealed that 1845 probes (correspond to about 1700 genes) were
differentially expressed between PPARc KD and control siRNA
(Spreadsheet S1). After hierarchical clustering, two distinct
expression patterns were observed with approximately 40% down
and 60% up-regulated in the PPARc KD. Henceforth, we will
refer to genes down-regulated and up-regulated in the PPARc KD
as induced and repressed by PPARc respectively. Analyzing the
expression profile day 4–6 separately, however, provided us with
760 probes differentially expressed with the majority of genes
induced by PPARc (Spreadsheet S2), 222 probes of which were
not present in the set including all time-points. The global
expression profile changed over the course of differentiation.
During the early stages of adipocyte differentiation, the proportion
of PPARc repressed genes (difference to control .1.5 fold) was
higher than that of genes induced by PPARc (Figure S1 A). This
relation was reversed at day 3, concomitant with the switch from
early to terminal adipocyte differentiation and marked by the
induction of adipogenic maintenance genes. Gene ontology
analysis for the combined set (day (22 to 6) and (4 to 6); 1656
genes with annotation) of differentially expressed genes using
PANTHER [18,19] showed an enrichment of genes involved in
lipid, fatty acid and steroid metabolism, amino acid metabolism
and generally genes with metabolic function. Only PPARc
induced genes were significantly associated with metabolic
processes while PPARc repressed genes were enriched in processes
associated with development and cell division (Figure S1 B).
Global map of PPARc and RXR binding sites
Having identified genes whose expression is PPARc dependent
during adipogenesis, we aimed to further uncover genes directly
regulated by PPARc through mapping PPARc binding sites on a
genome-wide scale. As RXR has been shown to be a hetero-
dimerization partner of PPARc [20], we also independently
mapped RXR direct binding sites. We posited that the overlay of
the RXR sites onto the PPARc sites could potentially improve the
identification of functional PPARc binding sites. In addition, from
our previous work, the digital count of ditags at binding loci is well
correlated with the transcription factor occupancy. Thus, the
combined analysis of PPARc and RXR binding ditag counts at
close locations may be an indication of the importance of specific
PPARc:RXR interactions during PPARc induced differentiation
at a genome-wide level.
In order to identify binding sites, we collected chromatin
immunopreciptation (ChIP) material from differentiated 3T3-L1
cells using PPARc and RXR specific antibodies. To maximize
ChIP enrichment, the samples were harvested on day 6 post
induction, when PPARc levels were found to be highest during the
differentiation process (Figure 1A). PPARc and RXR bound DNA
fragments were isolated from 3T3-L1 cells. Immunoprecipitated
DNA fragments were sequenced using the pair-end-tagging
approach and mapped to reference genome (mm8) [21,22].
3,211,429 of clone equivalents (ditags) were sequenced from the
PPARc ChIP-PET library and 1,646,083 ditags were sequenced
from the RXR library. Both libraries reached approximately 63–
65% sequencing saturation (see saturation analysis in supplemen-
tary material, Figure S2).
Overlapping PET fragments were clustered as before [23,24] to
form ChIP-PET clusters. The resultant ChIP-PET clusters were
then stratified based on the maximum number of overlapping
fragments within each cluster. For example, a non-overlapping
fragment is labeled as a moPET1 cluster, and as before, these are
considered background/noise [21], while a moPET3 cluster is one
where the maximum number of PET fragments overlapping at
any location within the cluster is three. (moPETn+ clusters is the
set of moPETi clusters, where i$n). Applying the adaptive
thresholding method [25], 2953 PPARc ChIP-PET clusters and
5142 RXR ChIP-PET clusters were found to be statistically
significant (FDR of #0.01) and henceforth referred to as putative
binding regions (Figure 2).
Similar to other nuclear hormone receptors such as the estrogen
receptor, the majority (75–88%) of the bona fide binding regions
of PPARc and RXR are within genes or within 100 kb of their 59
and 39end; with the plurality being within the genes (39–43%)
(Figure 3 A). The binding regions showed no obvious concentra-
tion in any specific genomic area when mapped to genome.
Genomic distribution of PPARc moPET1 and RXR moPET1
fragments were used to approximate background distribution
(Figure S11).
Such a coarse analysis, however, will not reveal potentially
significantly but less frequent positional clustering of binding sites.
To address this possibility, we assessed whether PPARc or RXR
would bind at a frequency greater than chance vis-a `-vis specific
gene boundaries such as the transcriptional start site (TSS). We
found that the proportion of binding sites of either NHR within
5 kb of the TSS was significantly higher than downstream of a
gene. When we mapped the frequency contours for PPARc and
RXR binding within 100 kbp 59 and 39 of TSS, we found a
distinct enrichment within approximately 5–10 kb of the TSS
(Figure 3B). No such bias was observed when the 39 prime end of
genes was assessed.
Heterodimerization of PPARc and RXR are evident in the
binding sites proximity
The heterodimerization between PPARc and RXR has been
previously determined on a small number of individual binding
sites and is thought to be the exclusive biochemical configuration
for transcriptional activation by PPARc [26,27]. Our data allowed
us to examine this issue at a genome-wide scale. Taking the middle
of ChIP-PET overlap region (i.e., a PET cluster) as the proxy for
actual binding site locations, as in [28], we plotted the ratio of the
observed distance distribution between binding sites of PPARc
and RXR (Figure 3C) and what would be expected in case of
random binding. We observed a significant co-localization of
PPARc and RXR binding sites within distances of 500 bp or less.
A Monte-Carlo assessment further confirmed that the enrichment
of paired PPARc/RXR binding sites is significant at FDR,0.05
when these bona fide individual binding sites are separated by
,300 bp (Figure 3C). We call these PPARc/RXR site-pairs
identified by our ChIP-PET sequencing as ChIP-PET heterosites,a s
they are the likely DNA interaction sites of putative PPARc:RXR
heterodimers (Henceforth, we would also use the term monosites
to refer to binding sites of PPARc (or RXR) where no RXR (or
PPARc/RXR Binding Sites
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most likely determined by the number of fragments constituting a
cluster and the initial shear size of the DNA fragments. As such,
we considered a maximum interval of 200 bp in identifying
heterosites. Individual NHR binding sites without another binding
cluster within 200 bp are called monosites. Validations of these
PPARc and RXR binding at the monosites and heterosites by
ChIP-qPCR (Figure 4) found that heterosites had a significantly
greater degree of occupancy than the monosites. Furthermore, this
degree of occupancy for any individual site was not observed in
undifferentiated cells (fibroblasts), where RXR is abundantly
expressed but PPARc is not (Figure S3). We then took 157 ChIP-
PET determined mono- and heterosites and subjected them to
ChIP-q-PCR validation for binding of PPARc and RXR
(Figure 4). The results of this validation first showed that on
average, the moPET counts correlated with the qPCR outcomes:
the higher the moPET, the greater the fold enrichment by qPCR.
The second observation is that almost all of the monosites as
determined by ChIP-PET for PPARc were also bound by RXR in
qPCR validation. The reverse was also true in that almost all
ChIP-PET based monosites for RXR also bound PPARc by
qPCR. This is supported by the fold enrichment levels of PPARc
or RXR at any binding site that exceeded the adaptive threshold
cutoff. Regardless of whether monosites or heterosites are used,
both NHR bound with the same relative degree to each binding
site (Table S4).What discrepancies were attributable to a small
number of low order binding sites of approximately 1.5–2 fold
enrichment where occupancy of the heterodimer partner could
not be detected. Given that each of the ChIP-PET sequencing
runs were only 63–65% saturated (Figure S2), we believe that the
heterosite calls missed by ChIP-PET is a function of sampling
error of sites with weaker NHR occupancy. Highly enriched sites
are most likely present in both libraries and sites with lower
enrichment are more likely to be present in only one of the
libraries. Supporting this, we found that the ChIP-PET monosites
had a lower level of enrichment for PPARc and RXR as
compared to the ChIP-PET heterosites upon ChIP-qPCR
validation (3.5–5.4 average fold enrichment for the monosites vs.
14.4–16.1 average fold enrichment for the strong heterosites;Wil-
coxon’s one-tailed test p,1E-4 in all cases) (Table S4). The
combination of our genome-wide ChIP-PET data and the ChIP
qPCR validation therefore suggest that PPARc and RXR interact
on the same DNA binding sites throughout the genome though of
differing intensities. This is consistent with the biochemical
evidence that PPARc and RXR act together as a heterodimer
in PPARc action. Our work extends this observation on a genome
wide scale. Combining both the PPARc and RXR sites we
identified a total of 7821 binding sites throughout the genome
Figure 2. Binding regions of PPARc and RXR are abundant but not unevenly dispersed. Genome-wide view of PPARc and RXR binding
regions, binned into 200 kbp blocks. No particular chromosomal concentration of bins containing PPARc only (red), RXR only (green), or both (blue)
was observed. Summary of the moPET counts for the PPARc and RXR ChIP-PET libraries. Good binding regions were identified using aberration
normalizing algorithm [25].
doi:10.1371/journal.pone.0004907.g002
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Spreadsheets S3, S4 and S5).
These sites therefore represent a substantial part of the genome-
wide pool of PPARc /RXR binding sites operative during
adipogenesis. Based on the validation rate we conclude that sites
with higher occupancy are more likely to be present in this pool.
Advancing a major aim of this study of identifying direct
PPARc/RXR target genes, we sought to further combine PPARc
dependent expression profiles with the genome-wide PPARc:RXR
binding site data. We extracted 278 probes on the Illumina
expression array which had PPARcmoPET2+/RXR ChIP-PET
heterosite(s) within 5 kb of the TSS, and 424 and 1494 probes had
respectively a PPARc or RXR site within 5 kb of their TSS
(Spreadsheets S3, S4 and S5). Based on our earlier analysis, the
ChIP-PET determined monosites would collectively represent sites
with a lower level of occupancy by the heterodimer than the ChIP-
PET heterosites. Of the 278 probes in proximity to a heterosite,
more than 31% (88) were regulated by PPARc activation
(P=1.91E-38). This compares to 14% (54) in proximity to PPARc
ChIP-PET monosites (P=2.57E-07), 13% (192) for RXR ChIP-
PET monosites (P=2.61E-16), and 9% for all probes on the
expression array (i.e., background). More specifically, probes
induced by PPARc are more commonly associated with RXR/
PPARc binding sites in proximity of the TSS, whereas there is no
association seen with genes repressed by RXR/PPARc activation
(Table 1). Thus, proximity of a binding site with a high level of
heterodimer occupancy to a TSS significantly increases the
likelihood that an adjacent gene will be up-regulated by PPARc
activation.
In an attempt to improve the identification of true target genes
and making use of true PPARc sites that went undetected (false-
negatives), we reasoned that RXR ChIP-PET monosites support-
ed by lower confidence PPARc binding (as defined by moPET
threshold of $2) would also identify good PPARc:RXR overlap
binding sites. Using the RXR monosites to catch PPARc sites that
were not called using the adaptive thresholding methods (false
negatives) (Figure S10). Indeed, qPCR validation of RXR
monosites that were also identified by a lower threshold moPET2
PPARc site gave us ,91% success rate for co-occupancy (Figure 4
S7, S8 and Table S4).
To examine this more closely, we collapsed the array probe sets
onto genes and classified a gene as target if it is both regulated
during adipogenesis and has at least one binding site (PPARc and
RXR) within 5 kb of the gene’s TSS. Since it is highly possible that
binding sites farther away from the TSS may also regular its
proximate gene, these criteria are likely to be more stringent. We
identified 75 high confidence target genes as defined by association
with heterosites and 180 lower confidence targets defined by
Figure 4. PPARc: RXR overlap sites show higher validation rate than nonoverlapping sites. ChIP Q-PCR was used for validation of binding
sites. 4 populations of binding sites were chosen for validation: PPARc monosites (no RXR sites within 200 bp), RXR monosites (no PPARc sites within
200 bp), low confidence PPARcmoPET2:RXR heterosites (within 200 bp) and high confidence PPARc:RXR heterosites (within 200 bp). High confidence
PPARc:RXR heterosites shows, on average, higher ChIP-qPCR enrichment than PPARc or RXR monosites and PPARcmoPET2:RXR heterosites. Shown is
the enrichment over an unspecific antibody control. Each data point represents mean value of 3 biological replicates, with error bars indicating the
standard deviation.
doi:10.1371/journal.pone.0004907.g004
Figure 3. PPARc and RXR binding regions are similarly distributed, with respect to nearest transcription unit. (A) Proportion of PPARc
and RXR binding regions’ locations relative to the nearest transcription units. PPARc monosites (no RXR sites within 200 bp), RXR monosites (no
PPARc sites within 200 bp), high confidence PPARc:RXR heterosites (within 200 bp of each other) and low confidence PPARcmoPET2:RXR heterosites
(within 200 bp of each other). Pie Chart on the right shows the distribution of the combined Pet1 fragments from both the PPARc and the RXR
libraries on the same genomic regions. Distribution of Pet1 fragments is assumed to be random (or close to) and was therefore chosen as background
comparison to visualize biases in the binding site distribution in the PPARc and RXR libraries. (B) PPARc binding regions, RXR binding regions, as well
as commonPPARc:RXR binding regions are biased towards 59 ends of known transcription units. Density of binding sites around TSS and 3 prime
ends of known genes (+/2100 kb) is plotted for PPARc, RXR, and conjoint PPARc:RXR binding sites. Coordinates for TSS and 3 prime ends of known
genes were extracted from UCSC KnownGenes database. C) Distribution of PPARc and RXR binding sites indicates interaction of PPARc and RXR.
Number of RXR binding sites in proximity to PPARc sites was determined. Plot of the ration of observed number of RXR sites within the distance
window indicated over the number of sites expected using randomly distributed genomic region. Monte-Carlo estimated FDR of PPARc:RXR co-
occurrences for various maximum distances between PPARc and RXR binding sites.
doi:10.1371/journal.pone.0004907.g003
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expression dynamics after PPARc activation (Figure 5). Our
analysis revealed that high confidence targets were induced at
significantly higher levels than lower confidence target genes.
Genes induced by PPARc are more commonly associated with
RXR/PPARc binding sites in proximity of the TSS (P=2.57E-07
to P=1.91E-38) (Table 1). No significant association is seen with
genes repressed by PPARc activation.
Binding sites show PPARc-dependent activity in vitro
To confirm that the PPARc binding sites identified by ChIP-
PET can regulate gene expression, we tested the ability of 6
putative PPARc DNA binding regions to mediate activation by
PPARc directly with reporter constructs (Figures 6C and S6).
These binding regions were selected based on ChIP q-PCR
validation and proximity to the TSS (Figure 6 A, B). Enrichment
of these binding regions by ChIP q-PCR was only observed in
adipocytes when compared with fibroblast (Figure S3). The
PPARc binding regions were cloned into a PGL3 vector with a
TATA box [23]. PPARc binding region from the known target
gene PLIN served as a positive control and the empty vector
(TATA alone) as the negative control. Reporter constructs were
transfected into 3T3-L1 fibroblasts without induction of endoge-
nous PPARc expression either alone or together with a PPARc
expression plasmid. 24 hrs after transfection, cells were stimulated
with 1 uM rosiglitazone or vehicle. Luciferase activity was
measure 24 h after stimulation. Four out of the six binding sites
tested showed substantial luciferase activity in PPARc transfected
Table 1. Genes induced by PPARc are more commonly associated with PPARc/RXR binding sites in proximity of the TSS.
# Probes
# of Probes
Regulated
# of Probes down-regulated
(fraction down) and P-value
enrichment
# of Probes up-regulated (fraction
up) and P-value enrichment
PPARc only 424 58 14(3.3%) P=0.98 44(10.4%) p=2.57E-07
RXR only 1494 192 54(3.6%) P=0.99 1384(9.2%) P=2.61E-16
PPARc2/RXR 278 88 12(4.3%) P=0.84 76(27.3%) P=1.91E-38
Total 20751 2070 1134(5.5%) 936(4.5%)
Proportion of regulated probes with a binding site for PPARc, RXR, and PPARcmoPET2+RXR is shown. Hypergenometric p-value was calculated comparing the
proportion of regulated probes among all probes on the array to the proportion of regulated genes with binding sites within 5 kbp to the proportion of all probes on
the array with binding sites within 5 kbp.
doi:10.1371/journal.pone.0004907.t001
Figure 5. Association of PPARc:RXR heterosites with differentially expressed genes. The majority of genes identified as direct PPARc
target genes are induced during adipogenesis. Genes differentially expressed during adipogenesis that are associated with a PPARc:RXR heterosite
were called high confidence PPARc target genes. Those with a PPARc or RXR monosite were labeled as medium confidence targets. Expression
profiles of high confidence, medium confidence, and no target genes are shown as heatmaps (day-2-6). Displayed is the fold difference of cells
treated with PPARc specific siRNA over non-targeting siRNA. Values representing the average of 3 biological replicates per conditions. Average fold
difference of expression levels between cells treated with PPARc specific siRNA over non-targeting siRNA was plotted for high confidence, medium
confidence, and no target genes was plotted across the timepoints.
doi:10.1371/journal.pone.0004907.g005
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PLoS ONE | www.plosone.org 7 March 2009 | Volume 4 | Issue 3 | e4907Figure 6. Functional validations of high confidence direct targets. High confidence targets were chosen for further validation to confirm
PPARc responsiveness. A) Localization of PPARc:RXR binding sites around putative target genes is shown schematically for genes which were further
selected for validation using reporter constructs. B) Binding of PPARc and RXR was confirmed by ChIP Q-PCR day 4 after adipogenesis induction.
Shown is the enrichment of target regions in the PPARc and RXR specific pull-down over an unspecific antibody control. Values represent the mean
of three biological experiments; error bars indicate standard deviations. C) Luciferase assays showing PPARc dependent activation of luc reporter in
3T3-L1 fibroblasts. Putative PPARc/RXR binding regions in proximity to Plin, PCX, Mgst1, Gpd1, Cops7b, Sncg and Pim3 were cloned into TATA box
containing pGL3 reporter construct. Reporter constructs were co-transfected with PPARc expression vector or empty vector as control. Putative PPRE
in binding region adjacent to Pim3 and SNCG were mutated to confirm functionality. Samples were treated with 1 uM Rosiglitazone or DMSO for
24 h prior to quantization. Luciferase activity was measured and normalized to renilla. Mutation of putative PPARc/RXR binding motif within the
binding region abrogates PPARc dependent activation of the luciferase reporter construct. Shown is the average of two biological replicates each run
in triplicates; with the standard deviations indicated as error bars. Asterisks denote significance (P-value,0.05, student T-test, two-tailed distribution.
doi:10.1371/journal.pone.0004907.g006
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tested showed only modest increase in luciferase activity. Further
increase in luciferase activity was observed in cells treated with
rosiglitazone. We have previously shown that the center of a PET
cluster represents the precise position of transcription factor
binding site in vivo [23]. By mutating an element which closely
resembled the PPARc/RXR binding consensus motif in one of the
binding regions adjacent to the pim3 and Sncg genes (Table S5 and
Figure S6), respectively, the reporter gene activation by PPARc
was markedly decreased. This suggests that the binding sites tested
can directly induce transcription in a ligand inducible manner and
that this induction is likely to be dependent on the specific
PPARc/RXR binding.
Known PPARc:RXR binding motif is overrepresented in
the binding regions
Applying de-novo motif discovery algorithm, Weeder [29] on the
heterosites and further refining the results, akin to what was done
in [28], we were able to uncover a weight matrix (A/
GGGNCAAAGGTCA) similar to the known weight matrix of
PPRE {(A/G)GGTCAAAGGTCA}, a direct hexad repeat that
represents PPARc:RXR joint binding motif. However, the
conspicuous absence of the consensus T in the calculated left
repeat and the attenuation of the signal from the T from the right
repeat from our genome wide data suggest that the earlier derived
consensus may have been a special case. Using the RXR
monosites we found a similar structure with two direct repeats,
but the T is absent in both sites (AGGGCAAA GGGCA).The
PPARc monosites, however, showed only a signal for a half-site
that, though more degenerate, resembles the AGGGCA motif
(Figures S4 and S9). In an alternative analysis, we screened the
center of the PPARc and RXR monosites and PPARcmoPET2+/
RXR binding regions for the frequency of occurrence of a
reported PPARc/RXR binding motif using previously described
PWMs [15,30,31]. All categories showed significant enrichment of
motif occurrence compared to background genomic regions
(Table S3). Comparing consensus motif occurrence in binding
regions adjacent to genes down-regulated and up-regulated by
PPARc, we found that repressed genes were less significantly
associated with a motif as compared to induced genes (Table S3).
Our results show that motif occurrence, like binding site
distribution itself, appears to be strongly biased towards regulated
genes, more specifically towards genes induced by PPARc.
Conservation of PPARc and RXR sites
Conservation of short sequence sites can be assessed using
different metrics. In this study, we examined whether the
sequences around the different categories of murine PPARc
and/or RXR binding sites would be conserved in the human.
200 bp interval around the binding sites was chosen to evaluate
association with conserved elements (100 bp up- and downstream
of the middle of the binding region). We observed that between
29–33% of the PPARc/RXR heterosites and RXR monosites
were conserved between mouse and human whereas PPARc sites
showed little diference from background in terms of conservation
(20% and 19% respectively). This low sequence conservation at
the binding sites is consistent with our experience with the
majority of transcription factors. When we examined the
conservation of binding sites within 5 kb of the TSS of PPARc
regulated vs. non-regulated genes, we found a significant
enrichment of conserved heterosites with upregulated genes
(65% upregulated vs. 42% down regulated, Figure S5). There
was no such enrichment with RXR or PPARc monosites or with
RXRPET1 sites which represent background. However, RXR
monosites and heterosites of lower quality showed increased
association with conserved elements as compared to both RXR
and PPARc:PET1 clusters. This suggests that a conserved function
of PPARc action is the induction of a number of specific
downstream genes.
PPARc target genes are significantly associated with
metabolic processes
Assuming that direct PPARc/RXR targets are responsible for a
large part of the observed biological effects of PPARc,w e
characterized these targets using PANTHER. As before, we
considered genes with at least one heterosite or monosite within
5 kb of their TSS a potential target gene. This restrictive
classification will leave out a considerable number of true target
genes containing a binding site further away than 5 kb, however it
will prevent the ‘‘dilution’’ of the true effectors of PPARc by
including a large number of false-positive targets. When all PPARc
and RXR binding sites are taken into consideration, the top
functional category that is overrepresented is lipid, fatty acid and
steroid metabolism (P=6.61E-08) followed by nucleic acid
metabolism (P=1.95E-06) and cell proliferation and differentiation
(P=7.02E-05) (Tables S1, S6, S7 and S8). When only the high
quality heterosites were considered, lipid, fatty acid and steroid
metabolism again was the top category, followed by apoptosis, and
then fatty acid metabolism. Gratifyingly, when compared to the
ontology of genes regulated by PPARc as assessed by expression
arrays (Figure S1B), the top intersects were lipid, fatty acid and
steroid metabolismand fattyacid metabolism.Thusbytwodifferent
approaches, one based on expression, and the second solely on
binding site association, PPARc primarily regulates a transcription-
al cassette that is involved in lipid and fatty acid metabolism.
siRNA knockdown of a set of PPARc direct targets affects
adipocyte differentiation
To assess the function of selected direct PPARc targets during
adipogenesis, we carried out gene knockdown experiments using
siRNA in 3T3-L1 cells. Adipogenic potential of the selected target
genes was evaluated by quantifying the reduction of lipid
accumulation in differentiated adipocytes in the absence of the
respective gene. Evaluated genes were selected from the high
confidence target genes defined by a transcriptional unit with
heterosites within 5 kb of their TSS and showing differential
expression pattern during adipogenesis. After Oil Red O staining,
lipid accumulation in cells was measured using a spectrometer set at
540 nm. Level of lipid accumulation inhibition ascribed to PPARc
KD was used as the positive control (40% reduction compared with
untreated adipocytes). A knockdown was considered affecting lipid
accumulation if it did not produce significantly higher lipid
accumulation (one-tailed t-test p.0.02) than that of PPARc KD.
The level of lipid accumulation of untransfected cells undergoing
adipogenesis after chemical stimulation was taken arbitrarily to
exhibit 100% adipogenesis. Whereas non-targeting siRNA had no
effect on the adipogenic phenotype, 6 of the 20 (30%) tested siRNAs
showed a reduction of lipid accumulation similar to that of PPARc
knockdown. The knockdowns that were biologically effective were
Pim3, Mnk2, Agt, Fsp27, Smaf1(adipogenin) and Pdzrn3, while other
targets showed no or very modest levels of inhibition of lipid
accumulation (Figure 7). These affects on lipogenesis are not due to
non specific cellular toxicity (data not shown).
Discussion
That PPARc with its heterodimerization partner, RXR, are key
regulators of adipogenesis [20,32–34]. Herein, we sought to detail
PPARc/RXR Binding Sites
PLoS ONE | www.plosone.org 9 March 2009 | Volume 4 | Issue 3 | e4907the transcriptional regulatory configuration of PPARc-RXR-DNA
interaction on a genome-wide scale using an established ChIP-
PET sequencing approach. Such genome-wide analysis of bona
fide NHR binding sites provides sufficient numbers to achieve
statistical power to uncover core characteristics of specific
transcription factor-DNA interaction by examining the population
characteristics of the DNA binding sites in a genome-wide scale.
By comprehensively assessing the binding profiles of each
heterodimer partner separately and then mapping their intersects,
we were able to assess the functional importance of the
heterodimer in PPARc signaling and function.
The observation of consistent PPARc/RXR interaction at
almost all high quality RXR binding sites was unexpected since
such exclusive interaction would not be expected given the
promiscuous nature of RXR as a heterodimerization partner [35].
In seeking an explanation for these findings, we constructed
potential mechanistic models based on the composite configura-
tion of the ‘‘population’’ of binding sites. This approach was used
Figure 7. Capacity for adipocyte differentiation after siRNA treatment of selected PPARc direct target genes. Undifferentiated 3T3-L1
cells were transfected with siRNAs that targeted genes that were selected on the basis of ChIP-PET binding for both PPARc and RXR, and expression
data. Transfected cells were brought to confluence and then treated with IBMX/DEX for 48 hrs, and then stimulated with insulin and rosiglitazone.
Cells were stained after 4 days of treatment using Oil Red O stain, and quantified for lipid accumulation using a spectrophometer set at an
absorbance of 540 nM. Percentage of adipogenesis, as measured by Oil Red O staining, was compared for each siRNA target to that of the non-
transfected differentiated cells (set at 100% adipogenesis). Non-targeting siRNA served as a control, while siRNA targeting PPARc served as a
threshold for adipogenesis inhibition. A gene target was considered affecting lipid accumulation if it did not produce significantly higher lipid
accumulation (one-tailed t-test p.0.2) than that of the PPARc KD. Starred bars represent genes that meet the criteria. Confluent fibroblasts, as well as
differentiated 3T3-L1 cells, that were not transfected with siRNA also served as controls to compare the effects of non-targeting siRNA on adipocyte
differentiation. Results indicate two biological replicates, each of which was transfected with siRNA to a final concentration of 50 nM.
doi:10.1371/journal.pone.0004907.g007
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genes involved in stem cell biology. The Oct4 and Nanog
transcription network regulates pluripotency in mouse embryonic
stem cells. [28]. Based on our data, we posit that true monosites
are fundamentally very weak binders and account for a small
proportion of the binding sequences. This is especially true for
PPARc where there were a significantly greater proportion of
weak occupancy sites (as measured by the ratio low/high
confidence sites) than with RXR (PPARc=62783/2953=21.3
vs. RXR= 33882/5142=6.6).We also observed that experimen-
tal heterosites are associated with consistently higher NHR
occupancy and more likely associated with genes induced by
PPARc. One plausible model is that our ChIP-PET experiments
were performed at day 4 post induction, where PPARc levels are
the highest and in the presence of the potent PPARc agonist
rosiglitazone, thus represents a cellular milieu that favors the full
utilization of the PPARc/RXR heterodimers in adipocyte
differentiation. We surmise that, under these conditions, the
excess PPARc could titer out the limited pool of RXR molecules
from its other heterodimeric partners during the course of
adipogenesis. Consistent with this observation is that despite
similar levels of RXR in undifferentiated 3T3L1 cells, the binding
of RXR to high confidence sites was uniformly lower than that
seen after adipogenic induction when PPARc expression is
dramatically induced (Figure S3). This suggests that the efficiency
of RXR binding at PPARc sites is augmented in the presence of its
heterodimerization partner. Though this mechanism has been
suggested in studies involving individual binding sites, our
genome-wide analysis suggests that the PPARc/RXR heterodimer
is a general requirement for optimal DNA binding throughout the
genome.
In addition, our data suggest asymmetric requirements for
PPARc and RXR in this heterodimerization process. RXR
appeared to have an almost 4 fold higher ratio of high quality to
lower confidence occupancy sites than PPARc. Moreover, de novo
motif analysis showed RXR binding sites gave a robust direct
repeat that resembled the canonical PPRE whereas the PPARc
motif appeared more degenerate.
Our global results have revealed other general characteristics of
PPARc/RXR binding as it relates to downstream function. First,
that proximity of a binding site to the TSS along with the level of
occupancy of the heterodimer predicts for association with
regulated genes, and in particular upregulated genes. We have
observed this with other transcription factors such as ERa, Myc,
and p53 in that proximity to the TSS (up to 50 kb) is statistically
associated with upregulated genes. Downregulated genes do not
have this position association with binding sites of their cognate
transcription factors. When coupled with the observation that the
evolutionary conservation of PPARc/RXR binding sites is greater
when adjacent to upregulated genes than downregulated genes
suggest that the primordial function of PPARc/RXR is the
induction of genes involved in lipid and fatty acid metabolism.
Extending the functional importance of PPARc/RXR tran-
scriptional regulation to adipogenesis, our assessment of the
ontologic classification of the genes in proximity to PPARc/RXR
heterosites shows significant enrichment for three major classes.
The most enriched are genes involved in lipid, fatty acid, and
steroid metabolism, and then genes involved in apoptosis. In a
broader analysis of all PPARc and RXR binding sites, lipid, fatty
acid, and steroid metabolism cluster remains the most enriched,
with other metabolic processes following. This suggests a
transcriptional network with PPARc/RXR at its core mediating
an appropriate transcriptional response to changing ligand (i.e.
fatty acids) concentration by fine tuning the levels of enzymes
involved in metabolic processes associated with fatty acid and lipid
metabolism. A comparison of the functional classification of
downstream targets of different transcription regulators is also
informative. The function of downstream targets of transcription
factors such as ERa, Oct4-Nanog, p53 and RELA [21,23,28,36]
include a significant number of other transcription factors
suggesting a ‘‘cascade’’ effect on transcription as a result of the
induction of a series of other transcriptional regulators. By
contrast, however, transcription factors are not overrepresented
among direct PPARc targets. While this is not ruling out any
crucial function for TFs in the process of adipogenesis downstream
of PPARc as was shown for C/EBPa and Stat5a, the enrichment
of enzymes involved in metabolic processes is very significant.
Only a limited number of genes are known to date to be direct
targets of PPARc, with the majority being involved in lipid
metabolism [27]. In this study we extended this number to about
250 putative target genes (Spreadsheets S3 and S6). On the
assumption that these direct target genes may have a central role
in the adipogenic action of PPARc/RXR activation, we examined
the biological significance of a number of direct target genes
identified in our study in the adipocyte differentiation process. We
hypothesized that by suppressing these direct targets of PPARc
using siRNAs targeted against them, we would be able to inhibit
adipogenesis, hence justifying the importance of these direct
targets in the PPARc adipogenic cascade. Indeed, of the 20
putative direct targets genes assessed using siRNA approaches, we
found that 6 or 30% showed inhibition of adipocyte differentiation
of 3T3-L1 cells when expression was attenuated using gene specific
siRNAs. Using this approach, we have demonstrated that selective
inhibition of PPARc direct targets do in fact play a crucial role in
the PPARc adipogenic cascade, even in the presence of
endogenous PPARc. These putative targets include genes
previously associated with obesity, while others have not been
well characterized. Pim3, which we demonstrate here as being a
direct target of PPARc is a serine threonine kinase that is
evolutionarily highly conserved. Mice lacking expression of Pim1,
Pim2, and Pim3 although viable and fertile show profound
reduction in body size at birth and throughout postnatal life
[37]. Although the contribution of Pim3 in mammalian develop-
ment needs further investigation, its role as an oncogene is well
documented. Aberrant Pim3 expression in cancer cells mediates its
anti-apoptotic effects by phosphorylating Bad [38,39]. This is
potentially significant, since PPARc is also highly expressed in
many cancers [40] and therefore may play a role in inhibiting
apoptosis via Pim3 expression. Additionally we have identified
novel PPARc direct targets that have previously been demon-
strated to promote lipid accumulation, regulate lipolysis and
promote triglyceride accumulation. These include FSP27/Cidec,
which has previously been reported to be regulated by C/EBP and
other C/EBP-like proteins and functions in regulating adipocyte
metabolism and enhancing triglyceride storage. FSP27 is
expressed at high levels in brown adipose tissue (BAT), liver and
white adipose tissue (WAT), and its expression is enhanced during
adipogenesis in primary rodent and human preadipocytes. In
addition, insulin exposure enhanced FSP27 transcript levels
[41,42]. Recent evidence suggests FSP27 regulates lipid accumu-
lation and triacylglycerol storage by binding to lipid droplets and
regulating their enlargement [42,43]. Adipogenin (SMAF1,
BC054059), another direct PPARc target, stimulates adipocyte
differentiation and development and is exclusively expressed in
adipocytes isolated from primary adipose tissues [44]. Recent
evidence suggests transmembrane proteins play a vital role in the
development of adipose tissue and obesity. The expression of
adiponutrin, a transmembrane protein, is regulated in human
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Adipogenin may function in a similar manner by regulating levels
of lipid stores during adipogenesis. We have shown that the
downregulation of angiotensinogen (Agt) inhibits adipogenesis in
3T3-L1 cells. AGT is secreted by WAT, is induced during
adipogenic conversion, and may contribute to the elevation of
blood pressure and several cardiovascular risk factors in obese
patients [46,47]. Lipid accumulation and adipocyte differentiation
is severely impaired when angiotensinogen levels are reduced.
Though the role of angiotensinogen in the differentiation of
adipoblasts has not been elucidated, angiotensinogen signaling has
been linked to leptin/leptin receptor signaling, insulin receptor
signaling and the metabolism of complex and glycerolipids, via
serpine1 [48]. GPRK7 (Mnk2), which phosphorylates eukaryotic
initiation factor 4E and which we show here as being a direct
target, also inhibits adipogeneis. The role of G-protein coupled
receptors in adipocyte biology is unclear. Of the numerous GPR
expressed, GPR120 and 43 has been linked with a possible
physiological role in adipose tissue development and adipocyte
differentiation. The levels of both receptors are highly expressed in
adipose tissues of mice fed on a high fat diet, and siRNA targeting
these receptors inhibited adipocyte differentiation [44,49]. In
addition to the gene targets that were transcriptional upregulated
by the PPARc/RXR heterodimer, we also investigated whether
KD of target genes that were transcriptionally downregulated by
the heterodimer could enhance adipogenesis. For this, we targeted
PDZRN3, which contained a heterosite within its promoter and
was downregulated by PPARc during the course of adipogenesis.
PDZRN3 is a PDZ domain containing RING finger 3 (PDZRN3)
that potentially has E3 ubiquitin ligase activity. Previous studies
have shown that PDZRN3 is expressed in the heart, skeletal
muscle and liver. Up-regulation of PDZRN3 during differentiation
of myoblasts into myotubes, and injury induced muscle regener-
ation has been described [50].
Although PDZRN3 has a role in myoblasts differentiation, we
observe a paradoxical finding during adipocyte differentiation. We
postulated that KD of PDZRN3 could enhance adipogenesis. Our
siRNA screen for PDZRN3 resulted in a decrease in adipogenesis.
This observation suggests a complex role for PDZRN3 in
adipocyte differentiation which will require further study. The
remaining direct targets of PPARc/RXR that were tested showed
no changes in lipid accumulation when targeted by their respective
siRNAs. These targets may not contribute directly to the
accumulation of lipids during the adipogenic process, but may
play a role in other metabolic processes or may play a redundant
role during adipocyte lipid accumulation and differentiation. Of
the interesting targets that showed no phenotypic changes include,
Mgst1 (MAPEG, Membrane Associated Proteins in Eicosanoid
and Glutathione metabolism family member) that may be involved
in inflammation and cellular defense and ECH1 (enoyl Coenzyme
A hydratase 1) which is involved in fatty acid beta-oxidation [51].
The rest of the targets that were screened have not previously been
reported to play a role in metabolic processes related to obesity.
Our study provides a comprehensive source of PPARc direct
targets to the scientific community studying adipogenesis to further
investigate the importance of this cascade sequence.
Taken together, our genome-wide analysis of the comprehen-
sive DNA interaction of PPARc and its heterodimerization
partner, RXR provides an enhanced understanding of global
functions of this NHR pair. Such a ‘‘population’’ approach helps
resolve the core actions by filtering the evolutionary noise inherent
in short motif recognition systems. Our observations suggest
several models for PPARc/RXR function that can now be tested
using the comprehensive binding database that we are providing.
Materials and Methods
Antibodies and Reagents
Rosiglitazone was obtained from Cayman Chemical (Ann
Arbor, MI, USA). 3-Isobutyl-1-methylxanthine and Dexametha-
sone was obtained from Sigma (St. Louis, MO, USA).
Primary antibodies- ApoA-1 (C-18):sc-19029, Adipsin (L-21): sc-
12403, Ob (H-146):sc-9014, A-FABP (C-15): sc-18661, PPARc
(H-100): sc-7196 and secondary antibodiesgoat anti-mouse IgG-
HRP, goat anti-rabbit IgG-HRP and donkey anti-goat IgG-HRP
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture, induction of adipocyte differentiation and
Oil Red O staining
3T3-L1 cell line was purchased from ATCC (Manassas, VA,
USA). Culture of 3T3-L1 cells and induction of differentiation was
performed as described in the Adipogenesis Assay Kit (Chemicon
International, Inc, USA).Briefly, differentiation of 3T3-L1 fibro-
blasts into adipocytes was performed by treating confluent cells
with 0.5 mM isobutylmethylxanthine (IBMX) and 0.25 mM
dexamethasone for 48 hrs and then with insulin (5 mg/ml) and
1 mM Rosiglitazone for 48 hrs. Media was replaced every 2 days.
Cells were cultured and harvested 6 days post rosiglitazone
treatment.
siRNA Transfection
SMARTpool siRNA and negative control siRNA (siCONTROL
non-targeting pooled) were purchased from Dharmacon, Inc
(Lafayette, CO, USA). Cells were transfected using the Lipofec-
tAMINE RNAimax reagent (Invitrogen) according to the
manufacturer’s protocol. Final concentration of siRNA was
50 nM.
Immunoblot Analysis
For detection of cellular proteins, cells were treated with SDS
sample buffer (62.5 mM Tris-HCl, 2% SDS, 10% glycerol,
50 mM dithiothreitol, 0.01% (w/v) bromophenol blue), sonicated
for 15 s, heated for 5 min at 95uC, and cooled on ice. Cell extracts
were electrophoresed on a 12% SDS-PAGE gel and transferred
onto nitrocellulose membrane. Blocking buffer (16 TBS, 0.1%
Tween 20, and 5%w/v nonfat dry milk) was added to the
membrane for 30 minutes at room temperature. Primary
antibodies were diluted in primary antibody dilution buffer
(16TBS, 0.1% Tween 20, 5% w/v BSA) and membranes were
incubated overnight at 4uC. Membranes were washed with wash
buffer (16 TBS, 0.1% Tween 20) and incubated with the
appropriate secondary IgG-HRP antibody in blocking buffer for
30 minutes at room temperature. Proteins were detected using
SuperSignal West Pico Chemiluminescent Substrate (Pierce,
Rockford, IL).
Chromatin Immunoprecipitation
Day 3 adipocytes were treated with 1 mM Rosi 24 hours prior
to ChIP procedures. ChIP was carried out as described previously
[23] using the H-100 anti-PPARc antibody, DN 197 anti-RXR
antibody or Rabbit IgG antibody (Santa Cruz). Following ChIP,
DNA was analyzed for PPARc and RXR binding at known
PPARc binding sites by real-time q-PCR.
Quantitative PCR
PCR quantification was performed on the ABI7500 Real-time
PCR System (Applied Biosystems) with 20 mL reaction volume
consisting of ChIP samples immunoprecipitated with IgG, RXR
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SYBR Green PCR Master Mix (Applied Biosystems). For each
PCR run, the samples underwent 40 amplification cycles.
Fluorescence was acquired at the conclusion of each cycle at
60 C during the amplification step.
ChIP-PET Library Construction and Sequencing
ChIP was performed as previously described [23] using
antibodies for RXR and PPARc (Santa Cruz, CA, USA). The
ChIP-PET analysis was performed as previously described [21]
using the UCSC mm8 genome as the reference genome. The
locations of the ChIP-enriched DNA present in the two libraries
were visualized using our in-house genome browser (T2G browser)
which was implemented in the context of the University of
California, Santa Cruz (UCSC) genome browser. ChIP-PET
fragments overlapping by at least 1 basepair were iteratively
clustered. Binding regions of PPARc and RXR were identified
from the set of all ChIP-PET clusters using adaptive thresholding
method similar to [25]. In brief: the adaptive threshold method is
based on a Monte-Carlo simulation. Significance for a binding site
was determined by computing the probability of a peak with a
certain size being observed in the library occurring by random
chance, given the total number of peaks in a defined interval. The
cut-off is therefore not fixed to a certain moPET number, for the
entire library, but changes depending on the background in any
given region.
ChIP-PET clusters that did not meet the adaptive thresholding
criteria but were at least of moPET2 and above are considered low
confidence sites. Closest genes were identified by using coordinates
for 59 and 39 position. Coordinates were extracted from UCSC
Known gene database or RefSeq annotated database to match
against genes present on the array.
Library Saturation Analysis
To assess the sampling adequacy of our libraries, we carried
sequencing saturation analyses on both the PPARc and RXR
ChIP-PET libraries. A total of 3,211,429 and 1,646,083 PET
reads were generated for the PPARc and RXR libraries
respectively, which identified around 549,000 unique ChIP
fragment locations for PPARc library and around 348,000 unique
ChIP fragment locations for RXR library. Using the chronological
information available from the sequencing pipeline coupled with
Monte Carlo simulations and similar to what was done in [21]. We
fitted a Hill Function to each empirical sequencing saturation
curve to estimate the asymptotic identifiable unique locations. The
saturation level was computed by taking the ratio of identified
unique locations over the total identifiable unique locations. A
saturation level of ,63% and ,65% were reached for PPARc and
RXR libraries respectively. The saturation curves are shown in
Figure S2.
Expression analysis
Total RNA was extracted using RNAeasy Kit (Qiagen). Biotin-
labeled cRNA was prepared using the Illumina TotalPrep RNA
amplification kit (Ambion) following the manufacturer’s instruc-
tions. cRNA was hybridized to Sentrix MouseRef-8 Expression
BeadChips. BeadChips were scanned and probe intensities were
measured. Probe intensities were normalized using Rank invariant
normalization (BeadStudio, Illumina). For statistical analysis of
expression changes between PPARc siRNA and control siRNA
treated cell we used PARTEK’s Genomics Suite. We employed 3-
way ANOVA to eliminate an obvious batch effect and used
corrected expression values thereafter. Probes with q#0.05
(Bonferroni corrected) were considered significantly changed.
Association of regulated genes with specific biological processes
was assessed using PANTHER (http://www.pantherdb.org/). List
of differentially regulated gene was uploaded and significance of
enrichment was calculated by comparing the number of genes
associated with a given process to the number of genes expected to
be associated on the basis on a genome wide reference list (NCBI
Mus musculus, 29917 genes). P-values were Bonferroni corrected
for multiple testing.
Constuction of plasmids and Luciferase Reporter Assays
PPARc/RXR ChIP-PET binding sites were amplified from
3T3-L1 genomic DNA by PCR and cloned into the pGL4-TATA
vector (a minimal TATA box upstream of pGL4- Basic) by
homologous recombination using the In-Fusion CF Dry-Down
PCR Cloning kit (Clontech, http://www.clontech.com). Putative
PPREs were mutated using the QuickChange Site Directed
Mutagenesis kit according to the manufacturer’s instructions
(Stratagene, http://www.stratagene.com). 3T3-L1 cells were
cotransfected with the ChIP-PET constructs, HSV-TK renilla
and PPARc expression vector with Lipofectamine 2000 (Invitro-
gen). After the cells were treated with 1 uM Rosiglitazone or
DMSO for 18–24 h, cell lysates were harvested and assessed for
firefly and renilla luciferase activity using the Dual Luciferase
Reporter Assay system (Promega, http://www.promega.com).
Assessing Significance of Distance Distribution
Genomic proximity between distinct elements can be used as a
good proxy for functional interplays between the elements. We
were interested to ascertain: (i) whether the identified PPARc and
RXR binding sites are preferentially concentrated around
Transcription Start Sites (which suggests direct gene regulatory
role), and (ii) whether the reported cooperation of PPARc and
RXR is evident at the genome scale. For the first task, we
compiled the distances of all sites to all TSS (based on UCSC
knownGene database) within 100 kbp away and grouped them
into 5 kbp bins. As a control, the same amount of sites was
randomly distributed in the genome and their distances to all TSS
were similarly compiled and binned. Plotted in Figure 3B is the
ratio, for each distance bin, of the binding site density from the
actual data to that of the randomly distributed control.
Similarly, for the second task, distances of all PPARc sites to all
RXR sites were computed and split into 200 bp bins. Figure 3C
shows the ratio of the observed occurrences in each bin to the
expected occurrences had the sites been distributed randomly and
independently. In addition to that, we estimated the Monte-Carlo
False Discovery Rate (FDR) of PPARc and RXR binding sites co-
occurrence within varying distances (Figure 3C).
Motif enrichment
To determine the presence of PPARc-RXR binding site motifs
(DR1) in the PPARc and RXR ChIP-PET genome-wide binding
site data sets, we analyzed the cluster sequences using the
Matinspector program, which is part of the Genomatix software
suite (Genomatix, Munich). The binding site predictions are based
on a position weight matrix algorithm and to compute the
statistical significance, we generated a background sequence set of
10,000 randomly selected 500 bp sequences, roughly matching the
9002 binding sites identified in the PPARc and RXR ChIP-PET
experiments. The analyzed ChIP-PET cluster sequences were
500 bp long, and defined using the center of the PET cluster as the
middle of the cluster and then expanding 250 bp on each side.
The p-values were computed under the binomial distribution and
were adjusted for multiple hypotheses testing using the conserva-
tive Bonferroni correction.
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PhastConsElements
For this analysis, we considered 20 bp binding regions centered
on the middle of ChIP-PET overlap. Binding region within 5 kb
from TSS of genes present in Illumina beadChip for which the
coordinates could be located were split into regulated and non
regulated genes. Based on the expression profile of the nearest
gene, the binding regions were grouped into those associated with
PPARc-regulated and non-regulated genes. A binding region was
said to be associated with conserved element if it overlaps with the
PhastConsElement, obtained from UCSC database.
De- novo motif construction
The de-novo motif discovery was carried out using Weeder [29]
on 100 bp sequences centered on the middle of heterosites peaks,
PPARc monosites, and RXR monosites. To overcome the 12 bp
limitation of Weeder, de-novo motifs that contained a pattern
matching to at least a half-site of the known PPRE consensus were
extended to a reasonable length that would contain the full PPRE
consensus and were refined in an EM-like optimization using
random genomic sequences as background [28].
Supporting Information
Figure S1 Gene expression dynamics and Biological Processes
during adipogenesis. Expression changes during adipogenesis are
hallmarked by PPARc induced genes and are biologically
meaningful. ANOVA with a 5% FDR cutoff was used to find
genes differentially expressed between 3T3-L1 cells treated with
PPARc specific siRNA and control siRNA, respectively. A)
Proportion of genes significantly up- or down-regulated, defined
as having a fold difference .1.5, at each time point. B) Results of
biological process analysis using PANTHER [http://www.
pantherdb.org/]. A number of biological processes are signifi-
cantly enriched among genes repressed (left panel) or induced
(right panel) by PPARc during adipogenesis. Statistical signifi-
cance was computed by comparing the number of genes in each
category to expected number derived from the total number of
genes in each process using NCBI mus musculus Ref Seq as
reference. P-values were Bonferroni corrected for multiple
hypotheses testing. Genes were categorized as repressed or
induced according to their average fold change throughout the
time course.
Found at: doi:10.1371/journal.pone.0004907.s001 (0.06 MB
DOC)
Figure S2 Library saturation analysis. Results from library
saturation analysis showed that (a) the PPARc library was ,63%
saturated, while (b) the RXR library was ,65% saturated. The x-
axis shows the amount of sequence reads collected and the y-axis
indicates the total unique genomic location obtained. The Hill
Function was used as analytical curve to determine the asymptotic
unique location attainable within the library.
Found at: doi:10.1371/journal.pone.0004907.s002 (0.04 MB
DOC)
Figure S3 PPARc/RXR heterodimer is a general requirement
for optimal DNA binding. High confidence targets were chosen
for binding of PPARc and RXR in undifferentiated (fibroblasts)
and fully differentiated (adipocytes) 3T3-L1 cells. Binding was
confirmed by ChIP Q-PCR. Values for fold enrichment of target
genes over unspecific antibody control (rabbit IgG) represent the
mean of three biological experiments, error bars indicate standard
deviations.
Found at: doi:10.1371/journal.pone.0004907.s003 (0.04 MB
DOC)
Figure S4 Significant motifs found in heterosites and monosites.
Sequence logos depicting the significant motifs found in the
heterosites, RXR monosites, and PPARc monosites. All the
extended motifs encode the half-site of PPARc binding elements.
Only the motifs originated from heterosites and RXR monosites,
however, seem to contain the full PPARc binding elements.
Found at: doi:10.1371/journal.pone.0004907.s004 (0.05 MB
DOC)
Figure S5 Binding sites are associated with phastCons Elements.
Binding sites (PPARc/RXR, PPARcPET2/RXR, PPARc, RXR,
PPARcpet1, RXRpet1) within 5 kb of a TSS were analyzed for
association with PhastCons Elments (UCSC genome browser;
http://genome.ucsc.edu/). PPARc/RXR heterosites showed a
stronger association with phastChonsElements close to regulated
genes then non regulated genes. Other binding categories showed
higher association with conserved elements than PPARcpet1 and
RXRpet1 as background.
Found at: doi:10.1371/journal.pone.0004907.s005 (0.03 MB
DOC)
Figure S6 Luciferase assays showing PPARc dependent activa-
tion of luc reporter in 3T3-L1 fibroblasts. Putative PPARc/RXR
binding regions in proximity to Plin, PCX, Mgst1,Gpd1, Cops7b,
Sncg and Pim3 were cloned into TATA box containing pGL3
reporter construct. Reporter constructs were co-transfected with
PPARc expression vector or empty vector as control. Putative
PPRE in binding region adjacent to Pim3 and SNCG were
mutated to confirm functionality (primers used in PCR amplifi-
cation and cloning are listed in Table S5, together with their
genomic locations). Samples were treated with 1 uM Rosiglitazone
or DMSO for 24 h prior to quantization. Luciferase activity was
measured and normalized to Renilla and cells transfected with
minimal TATA luciferase construct. Mutation of putative
PPARc/RXR binding motif within the binding region abrogates
PPARc dependent activation of the luciferase reporter construct
(mutations sites are highlighted in red). Shown is the average of
two biological replicates each run in triplicates; with the standard
deviations indicated as error bars. Asterix denotes p-values,0.05
(Student T-test, two tailed distribution).
Found at: doi:10.1371/journal.pone.0004907.s006 (0.12 MB
DOC)
Figure S7 Enrichment for PPARc and RXR correlates at
almost all tested sites. Correlation betweenPPARc and RXR
qChIP enrichment on randomly chosen PPARc and RXR PET4+
monosites, respectively, as well as on PPARc/RXR heterosites.
Plot shows a high degree of correlation between the enrichment
for PPARc and RXR as measured by ChIPqPCR at most sites
Found at: doi:10.1371/journal.pone.0004907.s007 (0.03 MB
DOC)
Figure S8 Distance between middle of PPARc and RXR
moPET clusters and heterosites correlates with Chip enrichment
and PET count. Enrichment in qPCR as well as moPET count for
both PPARc and RXR for heterosites is negatively correlated with
the distance between the two binding partners. This is a qualitative
statement to illustrate the characteristics of the heterosites. It
suggests however that the observed distance between the peaks of
the two binding sites decreases as the enrichement (occupancy)
gets better. Essentially, the better the resolution at the individual
binding site the better the overlap. Ideally the peak of two binding
sites should overlap.
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DOC)
Figure S9 Binding sites close to regulated genes show a higher
degree of motif occurrence. We scanned PPARc, RXR binding
regions and PPARc/RXR binding regions (1 kb with the middle
of the moPET region in the centre) for the occurrence of a
published PPARc consensus motif (AGGTCAAAAGGTCA)
while allowing for up to 3 mismatches. Ideally the motif is to be
expected to be located at the center of the cluster overlap (i.e. at
the middle of the peak). However, depending on the cluster size
the resolution might decrease. In addition, not all sites contain a
motif or the motif is degenerated. When plotting the motif
occurrence over the 1 kb window as density function, we found
that RXR binding sites as well as PPARc/RXR binding regions
showed a marked peak in motif density around the centre of the
binding regions. PPARc binding regions showed a motif
enrichment around the centre of the binding region as well,
however this enrichment appeared to be somewhat weaker. When
considering binding regions closer to genes all binding regions
showed further increase in motif occurrence with the maximum
for binding sites within 5 kb of regulated genes.
Found at: doi:10.1371/journal.pone.0004907.s009 (0.16 MB
DOC)
Figure S10 RXR binding sites are used to improve grading of
PPARc binding sites and reduce false negative rate in PPARc
data. Schematic illustration of our approach to consider
PPARcPET2+/RXR heterosites as high confidence sites: RXR
is used as quality binding site to ‘fish’ for a PPARc site within close
proximity that was not detected using the adaptive threshold
method. This helps to utilize the PPARc PET2+ cluster and hence
reduces the false negative rate. We used these sites to identify
direct targets.
Found at: doi:10.1371/journal.pone.0004907.s010 (0.05 MB
DOC)
Figure S11 Genomic distribution of PPARc moPET1 and RXR
moPET1 fragments gives an approximate background distribu-
tion. Fragments were pooled for a composite distribution chart in
Fig 3A.
Found at: doi:10.1371/journal.pone.0004907.s011 (0.08 MB
DOC)
Table S1 Biological process analysis of direct PPARc target
genes. Results of biological process analysis for direct PPARc
target genes using PANTHER [http://www.pantherdb.org/].
Genes were considered putative direct targets if at least one
binding site from any category (heterosites, PPARc monosites,
RXR monosites) was found within 5 kb of their TSS. TSS
coordinates were extracted from UCSC database KnownGenes.
Statistical significance was computed by comparing the number of
genes in each category to expected number derived from the total
number of genes in each process using NCBI mus musculus Ref
Seq as reference. P-values were Bonferroni corrected for multiple
hypotheses testing. Genes were categorized as repressed or
induced according to their average fold change throughout the
time course.
Found at: doi:10.1371/journal.pone.0004907.s012 (0.04 MB
DOC)
Table S2 Percent of regulated genes having binding sites.
Number of binding sites in proximity to genes is shown for
different classes of binding sites. Table lists total no. of binding sites
in proximity to a gene as opposed to no. of genes targeted by
PPARc. Gene coordinates were extracted from UCSC RefGene
Database.
Found at: doi:10.1371/journal.pone.0004907.s013 (0.03 MB
DOC)
Table S3 Calculation of PPARc/RXR binding motif occur-
rence. PPARc/RXR binding motif occurrence was evaluated in
different sets of binding sites. All PPARc, RXR and conjoint
PPARc2/RXR binding regions (500 bp) as well as binding regions
in proximity to regulated genes were screened for occurrence of a
described PPARc binding motif (PERO) using Genomatix. The
no. of occurrences is listed. The binomial p-value of motif
enrichment in the particular categories was calculated using 10000
randomly chosen sites.
Found at: doi:10.1371/journal.pone.0004907.s014 (0.03 MB
DOC)
Table S4 Comparison of ChIP-qPCR enrichments for the
different groups of binding sites. (A) No statistically significant
difference was observed between ChIP-qPCR enrichment of
PPARc andRXR across all groups of binding sites. (B) ChIP-
qPCR enrichment (on both PPARc and RXR antibodies) among
the heterosites was significantly higher than those of monosites,
although weak heterosites was of less significance.
Found at: doi:10.1371/journal.pone.0004907.s015 (0.03 MB
DOC)
Table S5 Primers used to amplify genomic regions for luciferase
constructs. Primers were selected to amplify 500 bp around the
binding regions of PPARg and RXR.
Found at: doi:10.1371/journal.pone.0004907.s016 (0.05 MB
DOC)
Table S6 Pathways implicated by PPARc PET2+/RXR
heterosites. Significant association of Pathways (PANTHER) with
genes regulated during adipogenesis which are in proximity (5 kb)
to PPARc PET2+/RXR heterosites.
Found at: doi:10.1371/journal.pone.0004907.s017 (0.15 MB
DOC)
Table S7 Pathways implicated by PPARc sites. Significant
association of Pathways (PANTHER) with genes regulated during
adipogenesis which are in proximity (5 kb) to PPARc sites.
Found at: doi:10.1371/journal.pone.0004907.s018 (0.17 MB
DOC)
Table S8 Pathways implicated by RXR sites. Significant
association of Pathways (PANTHER) with genes regulated during
adipogenesis which are in proximity (5 kb) to RXR sites
Found at: doi:10.1371/journal.pone.0004907.s019 (0.28 MB
DOC)
Spreadsheet S1 Day 22 to 6 differentially expressed genes.
Genes that are differentialy expressed during adipocyte differen-
tiation between cells treated with siRNA non-targeting versus
siRNA PPARg
Found at: doi:10.1371/journal.pone.0004907.s020 (0.15 MB
XLS)
Spreadsheet S2 Day 4 to 6 differentially expressed genes.
Genes that are differentialy expressed during adipocyte differen-
tiation on day 4 to 6 between cells treated with siRNA non-
targeting versus siRNA PPARg
Found at: doi:10.1371/journal.pone.0004907.s021 (0.07 MB
XLS)
Spreadsheet S3 PPARg clusters (2953). Location of PPARg
binding clusters
Found at: doi:10.1371/journal.pone.0004907.s022 (0.33 MB
XLS)
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PLoS ONE | www.plosone.org 15 March 2009 | Volume 4 | Issue 3 | e4907Spreadsheet S4 RXR clusters (5142). Location of RXR
binding clusters
Found at: doi:10.1371/journal.pone.0004907.s023 (0.57 MB
XLS)
Spreadsheet S5 PPAR_RXR_200 bp with annotation (907).
PPARg binding clusters that overlap with RXR binding clusters
that are within 200 bp of each other
Found at: doi:10.1371/journal.pone.0004907.s024 (0.19 MB
XLS)
Spreadsheet S6 Binding sites that are close to genes combined
with annotation. Binding clusters for PPARg or RXR that are
close to annotated genes
Found at: doi:10.1371/journal.pone.0004907.s025 (0.07 MB
XLS)
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